Evidence map›Paper›PMID 25624886›Full record

ArticleOncology letters2015

A rare case of eight multiple primary malignant neoplasms in a female patient: A case report and review of the literature.

Jiemin Zhao, Yan Tan, Yugang Wu, Wei Zhao, Jun Wu, Mei Ji, Liangrong Shi, Jingting Jiang, Changping Wu

Abstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Li-Fraumeni Syndrome With Six Primary Tumors-Case Report.Case reports in oncological medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiemin ZhaoDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Yan TanDepartment of Pathology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Yugang WuDepartment of Surgery, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Wei ZhaoDepartment of Pathology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Jun WuDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Mei JiDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Liangrong ShiDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Jingting JiangDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
Changping WuDepartment of Oncology, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu 213003, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the number of patients exhibiting multiple primary malignant neoplasms has been increasing. The current study reports the rare case of a 61-year-old Chinese female with eight histopathologically confirmed primary malignant neoplasms; to the best of our knowledge, such a high number of malignant neoplasms in one patient has not previously been described in the English literature. The tumors originated from the colon (five separate tumors over 32 years), the endometrium, the breast and the small intestine. It is important to diagnose multiple primary malignant neoplasms as such patients generally exhibit a more favorable prognosis compared with metastatic carcinoma patients. In addition, prolonged follow-up after surgery should be considered.

Indexed as

multiple primary malignant neoplasms

Identifiers

PMID25624886
PMCPMC4301539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.